In addition, high expression of X-ray repair cross complement 3 (XRCC3, a RAD51 paralog) indicated resistance to chemoradiotherapy and poor survival in ESCC patients [144]. This evidence concerns the gene XRCC3 and esophageal squamous cell carcinoma.